BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) shares were up 3.5% during trading on Monday . The company traded as high as $2.10 and last traded at $2.09. Approximately 11,352 shares were traded during trading, an increase of 146% from the average daily volume of 4,622 shares. The stock had previously closed at $2.02.
BioNexus Gene Lab Price Performance
The firm has a market cap of $5.06 million, a price-to-earnings ratio of -1.41 and a beta of 4.09. The firm’s fifty day moving average is $2.24 and its two-hundred day moving average is $3.19.
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last announced its earnings results on Friday, May 15th. The company reported ($0.22) earnings per share (EPS) for the quarter. BioNexus Gene Lab had a negative net margin of 54.70% and a negative return on equity of 37.97%. The company had revenue of $0.02 million during the quarter.
Institutional Investors Weigh In On BioNexus Gene Lab
About BioNexus Gene Lab
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
See Also
- Five stocks we like better than BioNexus Gene Lab
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.
